Physician profile

Ashish A Bhimani

Clinical Cardiac Electrophysiology · Atlanta, GA

NPI 1770600181

$51,154.30

in general payments reported to CMS, 2019-2025

32 companies · $9,119 in 2025

The $9,119 reported for 2025 was more than what 79% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

See the full distribution for Clinical Cardiac Electrophysiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$5,843.75
Food and Beverage$5,500.77
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$4,000.00
Travel and Lodging$2,287.41

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $24,223.50 2019-2025 Tacticath Ablation Catheter, Sensor Enabled, Aveir, Cardiomems
Biotronik INC. $14,346.51 2019-2021
Medtronic, INC. $5,888.15 2021-2025 Affera Mapping System, Micra, Pulseselect
Biosense Webster, INC. $1,828.20 2019-2025 Carto 3, Qdot Micro Catheter, Qdot Micro
Boston Scientific Corporation $1,385.72 2019-2025 Avvigo Guidance System, Farawave, Fineline II Sterox
Cvrx, INC. $892.74 2019-2025 Barostim Neo System
Janssen Pharmaceuticals, INC $527.36 2019-2023 Xarelto
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $249.88 2019-2025 Lifevest
Pfizer INC. $219.12 2019-2025
E.R. Squibb & Sons, L.L.C. $211.33 2019-2023 Eliquis
Acutus Medical, INC. $208.68 2021
Cardiva Medical, INC. $167.24 2021-2025 Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f
Amgen INC. $93.61 2019-2021
Novartis Pharmaceuticals Corporation $91.81 2021-2025
Atricure, INC. $90.44 2024-2025 Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Sanofi-Aventis U.S. LLC $89.39 2019-2024
Boehringer Ingelheim Pharmaceuticals, INC. $76.74 2022-2025 Jardiance
Irhythm Technologies, INC. $71.31 2024 Zio Monitor, Zio Xt Patch
Medtronic Vascular, INC. $67.37 2019
Edwards Lifesciences Corporation $53.97 2019-2024 Edwards Sapien 3 Ultra Transcatheter Heart Valve
Bayer Healthcare Pharmaceuticals INC. $47.71 2021-2025
Vital Connect, INC $44.97 2025 Vitalpatch Rtm
Ebr Systems, INC. $43.91 2025
Convatec INC. $35.66 2025
Baxter Healthcare $35.43 2024-2025 Hillrom - Cardiac Ambulatory Monitor
Philips North America LLC $30.68 2025 Ecc Solutions
Itamar Medical INC $25.99 2022
Innovation Technologies INC $24.38 2025 Irrisept
Actelion Pharmaceuticals US, INC. $24.23 2024 Opsumit, Uptravi
Daiichi Sankyo INC. $20.93 2021
Elutia, INC. $20.61 2019
Alnylam Pharmaceuticals INC. $16.73 2025 Amvuttra

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ashish A Bhimani

$51,154.30

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $9,119 reported for 2025 was more than what 79% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/306812/ashish-a-bhimani

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.